E-cigarettes 'help thousands successfully quit smoking'

Conclusion Stopping smoking remains the best thing you can possibly do for your health. Anything that can help reduce the number of people who smoke is likely to have a good impact on health. But although this study found e-cigarette use was linked to an increase in successful quit attempts, there are a number of things to be aware of: Attempting to quit with e-cigarettes alone may not be as helpful as attempting to quit using an NHS stop smoking service. Getting support and help for a quit attempt is thought to increase your chances of success fourfold. You can use NHS services and e-cigarettes together if you wish. The study can't prove using e-cigarettes is the direct reason for the improved rate of quit attempts as other confounding factors may have been involved. Some of the study results were surprising – for example, the researchers calculated that the rise in the legal age for smoking from 16 to 18 was associated with a bigger increase in quitting success rates than you'd expect. This casts some doubt over the results. Questions remain about whether e-cigarettes are really safe. While there's still work to do on this, Public Health England estimates the aids are 95% safer than using tobacco cigarettes. The important thing if you're a smoker is to give yourself the best possible chance of stopping smoking for good.   Links To The Headlines E-cigarettes 'help more smokers quit'. BBC News, September 14 2016 E-cigarette...
Source: NHS News Feed - Category: Consumer Health News Tags: Lifestyle/exercise Medication Heart/lungs Cancer Source Type: news

Related Links:

(Natural News) The Twitter thought police recently blocked a widely-respected, pro-life news outlet from accessing its account over a four-year-old tweet that contained facts about how homosexual men are prominent carriers of sexually-transmitted diseases (STDs). Dr. Gerard M. Nadal, a molecular biologist and microbiologist who also serves as president and CEO of the Coalition on...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Date: Friday, 11 30, 2018; Speaker: Lawrence Corey, M.D., President and Director Emeritus , Fred Hutchinson Cancer Research Center; Patricia Flatley Brennan, R.N., Ph.D, Director , National Library of Medicine; Carl W. Dieffenbach, Ph.D., Director, Division of AIDS; Maureen M. Goodenow, Ph.D., Director, Office of AIDS Reseach ; Avindra Nath, M.D., Senior Investigator, National Institute of Neurological Disorders and Stroke; Daniel Appella, Ph.D., Senior Investigator, National Institute of Diabetes and Digestive and Kidney Diseases; Dima Hammoud, M.D., Investigator , NIH Clinical Center; Building: Building 38A (Lister Hill National Center)
Source: NIH Calendar of Events - Category: American Health Source Type: events
THURSDAY, Oct. 18, 2018 -- Integration of plasma next-generation sequencing (NGS) into the routine management of metastatic non-small cell lung cancer (NSCLC) results in an increase in the detection of therapeutically targetable mutations, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
ConclusionWe developed a predictive model using machine learning that could represent a useful and easy-to-access tool for the selection of high ODX RS patients. After additional evaluation with large data and external validation, worldwide use of our model could be expected.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Abstract Background and objectives People living with HIV/AIDS are at increased risk of developing cancer. The goals of this study were to obtain data on the prevalence of HIV in the cancer population and vice versa at a major tertiary care cancer and HIV center in North India. Methods This cross-sectional study was conducted over a 3-year period from July 2013 to June 2016, wherein successive HIV positive patients from an anti-retroviral therapy (ART) center were screened for malignancy. Simultaneously, successive cancer patients at the cancer center were screened for HIV. Baseline demographic details, risk facto...
Source: Current HIV Research - Category: Infectious Diseases Authors: Tags: Curr HIV Res Source Type: research
Malignancies have become a leading cause of morbidity and mortality in people living with HIV (PLHIV). The primary endpoint of our study was to describe the epidemiology of acquired immunodeficiency syndrome (AIDS)-defining cancers (ADCs) and non-AIDS-defining cancers (NADCs). Epidemiological disparities, mortality predictors and survival analysis within the two groups of patients were key secondary endpoints.
Source: Journal of Infection and Public Health - Category: International Medicine & Public Health Authors: Source Type: research
This study aimed to review the effect of decision aids on men's screening intention, screening utilization, and the congruence between intentions and uptake.Evidence acquisitionData sources were searched through April 6, 2018, and includedMEDLINE, Scopus, CENTRAL, CT.gov, Cochrane report, PsycARTICLES, PsycINFO, and reference lists. This study included RCTs and observational studies of decision aids that measured prostate screening intention or behavior. The analysis was completed in April 2018.Evidence synthesisEighteen studies (13 RCTs, four before–after studies, and one non-RCT) reported data on screening intentio...
Source: American Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research
CONCLUSION: Apparently, research has to be centered on the natural history of breast cancer in order to provide responses concerning the questions raised by the overdiagnosis controversy. PMID: 30316554 [PubMed - as supplied by publisher]
Source: Revue d Epidemiologie et de Sante Publique - Category: Epidemiology Tags: Rev Epidemiol Sante Publique Source Type: research
Researchers at the National Cancer Institute (NCI) have developed a highly active variant of the catalytic domain APOBEC3G with higher ssDNA affinity. This variant may be used to develop therapeutics for AIDS, and may also be used as a tool of gene editing techniques. This hyperactive variant of the human APOBEC3G protein (hereby called CTD2) can be used as a tool to edit human genes in combination with the CRISPR/Cas9 system. CTD2 is selective to a specific target DNA sequence, soluble, and catalytically hyperactive, which makes CTD2 the ideal molecule to use in the aforementioned gene editing, using the CRISPR/Cas9 syste...
Source: NIH OTT Licensing Opportunities - Category: Research Authors: Source Type: research
A growing number of people, mostly Americans, is forced to use crowdfunding sites to ask for money to cover medical expenses. While in many cases, the option is a potential source of hope binding people together for a good cause that would otherwise be lost due to financial reasons, the phenomenon also shows the desperate state of a healthcare system where victims of terrible illnesses have to “commodify” themselves on online donation forums. Should it stay that way? Should we fear for a dark future of health insurance in some parts of the world? The patchwork called crowdfunding Kickstarter, GoFundMe, Indiegog...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Health Insurance Healthcare Design Social media in Healthcare crowdfunding digital health digital health insurance ethics future health data medical medical expenses Source Type: blogs
More News: Cancer | Cancer & Oncology | Cardiology | Chantix | Health | Heart | HIV AIDS | International Medicine & Public Health | Legislation | Nicotine | Nicotine Replacement Therapy | Science | Smokers | Sports Medicine | Study